Cargando…

Antibodies to watch in 2017

Over 50 investigational monoclonal antibody (mAb) therapeutics are currently undergoing evaluation in late-stage clinical studies, which is expected to drive a trend toward first marketing approvals of at least 6–9 mAbs per year in the near-term. In the United States (US), a total of 6 and 9 mAbs we...

Descripción completa

Detalles Bibliográficos
Autor principal: Reichert, Janice M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297518/
https://www.ncbi.nlm.nih.gov/pubmed/27960628
http://dx.doi.org/10.1080/19420862.2016.1269580